Urgent maxillectomy in infants for rare infantile maxillary tumors

Hazem E Amer1, Asser A Sharkawy, Ahmed Musad

  • 1Department of Otolaryngology, Mansoura Faculty of Medicine, Gomhoria Street, Mansoura 35516, Egypt.

Insights

Surgical management of rare infant tumors, Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Epithelioid Hemangioendothelioma (EHE), achieved complete tumor resection in all cases. Complete excision proved curative for these pediatric maxilla swellings.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Maxillofacial Surgery

Background:

  • Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Epithelioid Hemangioendothelioma (EHE) are rare pediatric neoplasms.
  • These tumors can present as slow-growing, painless swellings of the maxilla in infants.
  • Early diagnosis and surgical intervention are crucial for optimal outcomes.

Purpose of the Study:

  • To present surgical experience with definitive management of MNTI and EHE in infants.
  • To highlight the efficacy of surgical resection for these rare pediatric tumors.
  • To review the long-term outcomes of surgical intervention in a pediatric cohort.

Main Methods:

  • Retrospective review of four male infants diagnosed with MNTI (n=3) or EHE (n=1).
  • Preoperative imaging included CT scans and MRI.
  • All patients underwent surgical intervention for tumor removal.

Main Results:

  • Complete tumor resection was achieved in all four infants.
  • No residual tumor or recurrence was observed post-surgery.
  • The mean age of patients was 6 months (range: 2-9 months).
  • No adjuvant chemotherapy or radiation therapy was required.

Conclusions:

  • MNTI and EHE are rare but treatable infant tumors of the maxilla.
  • Preoperative imaging is essential for surgical planning.
  • Complete surgical excision is the definitive and curative treatment modality.
Abstract

Related Concept Videos